Dear All,
sorry for the late reply. I appreciate the number of replies and attempts to resolve this (pun intended)
I attempted method development on Waters uBondapak, C18, 7.8 x 300 mm, 10 um particle size.
the reason for using these dimensions is that I intended to incubate cell homogenates with some compounds I'd synthesised. I was then taking the incubant and diluting with 1.2 mL mobile phase, followed by filtration.
Essentially 1 mL injected onto column.
it transpired after this that some of my chemistry wasn't working, so Im focused on that right now...
I will say that the target molecules (thymidine analogues) are quite lipophilic, so my reasoning is that even after deprotection of the thymidine scaffold, the molecules should still be lipophilic enough not to elute too early. I am almost certain that they will elute significantly later than ATP.
but first I must make them, and characterise them, before handing over to biologists!!
edit: it is quite late so I will return to this thread on monday and deal with the various comments/suggestions
I'm thankful for this community